Welcure Drugs & Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported revenue was INR 0.355 million compared to INR 0.069 million a year ago. Net loss was INR 0.272 million compared to INR 0.024 million a year ago. Basic loss per share from continuing operations was INR 0.002. Diluted loss per share from continuing operations was INR 0.002.
For the nine months, revenue was INR 0.349 million compared to INR 0.159 million a year ago. Net loss was INR 1.56 million compared to INR 0.087 million a year ago. Basic loss per share from continuing operations was INR 0.012 compared to INR 0.001 a year ago. Diluted loss per share from continuing operations was INR 0.012 compared to INR 0.001 a year ago.